Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

CHEK - Check-Cap Ltd


IEX Last Trade
1.88
-0.050   -2.660%

Share volume: 3,911
Last Updated: Fri 30 Aug 2024 09:23:08 PM CEST
Surgical and Medical Instrument Manufacturing : -0.56%

PREVIOUS CLOSE
CHG
CHG%

$1.93
-0.05
-2.59%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
22%
Profitability 25%
Dept financing 10%
Liquidity 46%
Performance 16%
Company vs Stock growth
vs
Performance
5 Days
-0.26%
1 Month
-5.75%
3 Months
-17.75%
6 Months
-15.85%
1 Year
-20.46%
2 Year
328.41%
Key data
Stock price
$1.88
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
$0.00
52 WEEK RANGE
$1.78 - $4.63
52 WEEK CHANGE
-$0.35
MARKET CAP 
11.029 M
YIELD 
N/A
SHARES OUTSTANDING 
5.851 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.17
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$6,067
AVERAGE 30 VOLUME 
$6,071
Company detail
CEO: Alex Ovadia
Region: US
Website: http://www.check-cap.com
Employees: 91
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

check-cap is a clinical stage medical diagnostics company leading the development of the first ingestible imaging capsule that utilizes low-dose x-rays for crc screening. the check-cap device requires no bowel preparation or invasive procedures, and is designed to detect clinically significant polyps with a high degree of sensitivity. check-cap's advanced technology has been proven in animals, and is designed to offer several advantages compared to current screening procedures. founded in early 2005, check-cap recruited a team of world-class experts in physics, software engineering, electronics, mechanics and physiology, who have been developing a multi-disciplinary imaging solution for imaging and screening of the colon. the system includes a capsule, a receiver, proprietary imaging software and an associated database for web based access and analysis. check-cap's advanced technology has been proven in animals and promises to offer several significant advantages compared to other colo

Recent news